Form 4: Roivant Sciences CFO Richard Pulik Reports Acquisition of Restricted Stock Units and Stock Options

Richard Pulik, CFO of Roivant Sciences Ltd., reports the acquisition of restricted stock units and stock options.

Summary

• Richard Pulik, CFO of Roivant Sciences Ltd., filed a Form 4 detailing changes in beneficial ownership.
• On April 21, 2025, Pulik acquired 141,464 common shares through restricted stock units (RSUs) and 180,413 stock options.
• The RSUs vest starting thirteen months from April 20, 2025, with 25% vesting initially and the remainder in equal quarterly installments.
• The stock options vest starting one year from April 20, 2025, with 25% vesting initially and the remainder in equal monthly installments.
• The exercise price for the stock options is $10.04.
• Following the reported transactions, Pulik directly owns 407,352 common shares and 180,413 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating standard compensation practices. The acquisition of equity may be viewed positively, but it's not a major event.

Positives

• The acquisition of RSUs and stock options suggests confidence in the company's future performance from the perspective of the CFO.
• The vesting schedules for both RSUs and stock options incentivize long-term commitment from the CFO.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Comparison to Industry Standards

• Stock option and RSU grants are a common form of executive compensation in the pharmaceutical and biotech industries, used to align management incentives with shareholder value.
• Vesting schedules, such as the quarterly and monthly installments described, are typical for these types of equity awards.
• Comparable companies like Pfizer, Johnson & Johnson, and AbbVie also utilize stock options and RSUs as part of their executive compensation packages.

Stakeholder Impact

• The acquisition of RSUs and stock options aligns the CFO's interests with those of the shareholders, incentivizing him to work towards increasing the company's value.
• Employees may view this as a positive sign, indicating the company's commitment to its leadership.

Key Dates

Keywords

Roivant Sciences, Richard Pulik, CFO, Form 4, Beneficial Ownership, Restricted Stock Units, Stock Options, ROIV